Latanostad (Latanoprost)

Latanoprost activates prostaglandin F (FP) receptors in the eye, which remodels the extracellular matrix of the ciliary body and increases uveoscleral outflow of aqueous humor, resulting in reduced intra‑ocular pressure.

The dosing regimen for Latanostad is determined by the prescribing ophthalmologist. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and schedule must follow the clinician’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Latanostad, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Latanostad (latanoprost) is a first‑line prostaglandin analog, often preferred for its once‑daily dosing and strong IOP‑lowering effect. Alternatives include beta‑blockers, alpha‑agonists, carbonic anhydrase inhibitors, and other prostaglandin analogs, each with distinct efficacy, side‑effect profiles and dosing requirements.

Latanostad should be stored at room temperature, protected from light and moisture, and kept in its original container. Do not freeze the product, and discard any solution that appears discolored or contains particles.

Latanostad is applied as an ophthalmic solution. The patient should wash their hands, tilt the head back, pull down the lower eyelid, and instill one drop into the prescribed eye(s) without touching the tip to the eye or surrounding structures.

Serious risks include severe ocular inflammation such as uveitis, corneal edema, paradoxical increase in intra‑ocular pressure, and rare allergic reactions that may cause swelling, itching or vision loss. Prompt medical attention is required if any of these occur.

Latanostad is contraindicated in patients with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or inflammation. Caution is also advised for individuals with a history of herpetic eye disease or those using certain other ocular medications.